Manulife Raises S$500 Million in Subordinated Notes to Boost Tier 2 Capital

  • Manulife priced a S$500 million offering of 2.880% subordinated notes due June 4, 2036.
  • The notes qualify as Tier 2 capital and will bear interest at a fixed rate until June 4, 2031, then float over the five-year SORA OIS rate.
  • Manulife may redeem the notes in whole starting June 4, 2031, subject to regulatory approval.
  • The offering is expected to close on June 4, 2026, and will be listed on the SGX-ST.

Manulife's S$500 million subordinated notes issuance underscores its focus on strengthening Tier 2 capital, a critical component for meeting regulatory requirements and supporting risk-weighted assets. The move aligns with broader industry trends where insurers are optimizing capital structures to navigate evolving regulatory landscapes and market conditions. The notes' pricing and terms will be closely watched as indicators of investor sentiment toward Manulife's strategic positioning.

Capital Efficiency
How Manulife will deploy the additional Tier 2 capital to support growth or regulatory requirements.
Market Conditions
Whether the favorable pricing of the notes reflects broader investor confidence in Manulife's long-term strategy.
Regulatory Dynamics
The pace at which regulatory approvals for note redemption could impact Manulife's financial flexibility.